Aurobindo Pharma’s $900 Million Acquisition of Novartis’ Sandoz Generic Assets

Ambrogio Visconti

Baker Botts advised Novartis on the sale Novartis today has agreed to sell selected portions of its Sandoz US portfolio, specifically the Sandoz US dermatology business…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Ambrogio Visconti

…

This content is for Standard 1 Year members only.
Login Join Now